Interstitial cystitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 80 years, regardless of gender; 2.Patients clinically diagnosed with cystitis or bladder cancer, with pre-enrollment pathological histological or cytological examination confirmed by two or more pathologists; 3. Complete medical records during the study period: age at diagnosis, BMI, comorbidities, family history; pre-treatment blood routine, albumin and prealbumin, CRP, D-dimer, and imaging data; intraoperative findings, post-operative pathological examination of the primary lesion size and location, etc.
Exclusion criteria
Exclusion criteria: 1. Age less than 18 years or greater than 80 years; 2.Suffering from other serious urinary system diseases, such as renal failure, urinary tract infection, etc; 3.Having serious systemic diseases, such as cardiovascular disease, abnormal liver function, etc; 4. Lacking key data (such as pathology reports, symptom scores, etc.); 5. Having active infectious diseases such as HIV, hepatitis B, hepatitis C, or active rheumatic diseases; 6. The investigator deems the patient unsuitable for enrollment, for example, having a serious or uncontrolled bacterial, fungal, or viral infection that may interfere with the patient's participation in this study or evaluation of the study results; 7. The patient is lost to follow-up without justifiable reason during the study; 8. The patient or their family refuses to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder symptom score;Bladder function index;Repair of bladder mucosal barrier; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score;Incidence of adverse events;Blood and urine biochemical indicators; | — |
Countries
China
Contacts
Zhejiang Cancer Hospital